Last reviewed · How we verify
Role of PET/CT With Fluorine-18 Tracers and of Diffusion Weighted Whole-body MRI in the Early Detection of Bone Metastases in Prostate Cancer (FLUPROSTIC)
Compare PET/CT and MRI for the early detection of bone metastases of prostate cancer: diagnostic performance and impact on the patient management.Determine the lowest cost strategy according to the precise clinical circumstances.
Details
| Lead sponsor | Assistance Publique - Hôpitaux de Paris |
|---|---|
| Status | COMPLETED |
| Enrolment | 112 |
| Start date | 2011-12 |
| Completion | 2014-12 |
Conditions
- Prostate Cancer
Interventions
- performance of PET/CT and whole-body MRI
Primary outcomes
- bone metastases — within 6 months
Follow up data (histology, imaging, PSA levels) during 6 months to determine the standard of truth and the adequacy of the management decided on basis of imaging modalities.
Countries
France